论文部分内容阅读
自2000年6月至2001年6月一年间,我院应用磷霉素与双黄连注射剂,联合治疗小儿急性上呼吸道感染68例。经医学统计学处理显示:有效56例,占82.4%;显效8例,占11.7%;无效4例,占5.8%;不但毒副作用少、价格适中,更大的优点是不需要作过敏试验。所以,患儿和家长都乐于接受,尤其是夜间急诊,医护人员不必担心过敏反应,在基层医疗单位便于应用与推广。病例选择:全部68例均符合1994年大连儿科会议诊断标准。临床表现发热63例,占92.6%;咳嗽59
From June 2000 to June 2001 year, our hospital application of fosfomycin Shuanghuanglian injection, combined treatment of children with acute upper respiratory tract infection in 68 cases. The results of medical statistics showed that: 56 cases were effective, accounting for 82.4%; 8 cases were markedly effective, accounting for 11.7%; 4 cases were ineffective, accounting for 5.8%; not only less toxic and side effects, but also moderate price. The greater advantage was that no allergy test was required. Therefore, children and parents are willing to accept, especially emergency at night, medical staff do not have to worry about allergic reactions, and facilitate the application and promotion of primary medical units. Case selection: All 68 cases are in line with the 1994 pediatric conference diagnostic criteria. Clinical manifestations of fever 63 cases, accounting for 92.6%; cough 59